BCTX,BriaCell Therapeutics Corp. | Healthcare

Healthcare

BCTX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

BriaCell Therapeutics Corp.BCTX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

15.11M

Revenue (ttm)

n/a

Net Income (ttm)

-11.59M

Shares Out

3.71M

EPS (ttm)

-6.92

PE Ratio

n/a

Forward PE

n/a

Dividend

n/a

Ex-Dividend Date

n/a

Volume

3,989

Open

4.070

Previous Close

4.010

Day's Range

4.081 - 4.150

52-Week Range

0.350 - 7.870

Beta

1.71

Analysts

Strong Buy

Price Target

32.00 (+678.59%)

Earnings Date

Mar 12, 2025

Description >

BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer.

Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab.

The company also develops Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types.

It has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Latest News >

Inflation slowed more than expected last month, but prices remain high -- here's what's rising most

Mar 22, 2025

Key takeaways The current annual inflation rate is 2.8%, still stubbornly above the Fed's 2% target. Consumers pay more close attention to cumulative inflation, and prices are 23.3% more expensive today than they were before the coronavirus pandemic recession began in February 2020. The Federal Reserve cut interest rates a full percentage point across three consecutive meetings in 2024, but...

Bitcoin To Flourish With Or Without Trump's Support, Says Expert: Fed's Rate Cuts Could Make People More 'Inclined' To Buy BTC

Mar 22, 2025

Bitcoin (CRYPTO: BTC) is expected to reach a six-figure valuation by 2025, according to Nigel Green, CEO of deVere Group. This prediction comes despite the lack of explicit support from U.S. President Donald Trump. What Happened: In a recent video update, Green discussed the potential for Bitcoin to outshine gold if the Federal Reserve opts to reduce interest rates this year. He pointed...

Bayer hit with $2 bln Roundup verdict in US state of Georgia cancer case

Mar 22, 2025

BERLIN, March 22 (Reuters) - Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said late on Friday. The verdict, which Bayer said on Saturday it would appeal, is one of the largest legal settlements...

Pi Network’s PI Finally Rebounds, Bitcoin (BTC) Calm at $84K (Weekend Watch)

Mar 22, 2025

Bitcoins price consolidation around the $84,000 level continues as the asset has failed to breakout in either direction over the past week or so, despite a few attempts. Most altcoins sit quietly today, with little to no gains. PI has popped up by 9% after a recent landslide, while HYPE has surged by double digits. BTC Calm at $84K Last...